-
Here's Why OXiGENE Surged 65% Early Tuesday Morning
Tuesday, May 24, 2016 - 9:10am | 307Read More...Shares of OXiGENE Inc (NASDAQ: OXGN), a nano-cap biopharmaceutical company that focuses on the development of vascular disrupting agents for the treatment of cancer, surged higher by more than 65 percent early Tuesday morning. Investors and traders reacted to OXiGENE's announcement that the "...
-
OXiGENE Spikes 13% Following Receipt Of Fast Track Designation
Wednesday, March 30, 2016 - 10:59am | 236Read More...Shares of OXiGENE Inc (NASDAQ: OXGN), a nano-cap biopharmaceutical company that focuses on the treatment of cancer, spiked higher by 13 percent on Wednesday after the company announced that the U.S. Food and Drug Administration granted a Fast Track designation for one of its drugs. Oxigene...
-
Did OXiGENE Win a Crucial Battle In the Fight Against Cancer?
Wednesday, March 12, 2014 - 4:52pm | 224Read More...On Tuesday, OXiGENE (NASDAQ: OXGN) announced that a Phase 2 trial of its ZYBRESTAT ovarian cancer drug has “met its primary endpoint of a statistically significant increase in progress-free survival” of patients with ovarian cancer. Patients given a combination of ZYBRESTAT with an already...
